Rocket Lab's Q3: Revenue Records Can't Hide the Neutron Problem — But a Supply Desert Keeps Customers Locked In

Rocket Lab posted a sixth consecutive record quarter at $268M, but a void defect in Neutron's tank pushed first flight to 2027. Customers aren't leaving because there's nowhere else to go until ~2030.

Rocket Lab's third quarter tells a story of two companies operating under one ticker. The first is a profitable, vertically integrated small-launch and satellite platform business growing at 73% year-over-year, producing an Electron rocket every eight business days, and sitting on $3.57 billion in backlog. The second is a medium-lift rocket program that just found a structural defect in its first-stage propellant tank and won't fly until 2027.

The headline number is $268 million in revenue, the sixth consecutive quarterly record. Space Systems now accounts for 48% of total backlog, marking the company's deliberate pivot from launch-only operator to end-to-end space services provider. GAAP gross margins improved to 35%, driven by higher Electron launch cadence and high-margin component sales from recent acquisitions. The quarter also brought $1 billion in new launch bookings — a figure management attributes to global launch supply constraints and Rocket Lab's track record of actually delivering payloads to orbit. Neutron's delay is the crack in the narrative. A void discovered in the Stage 1 propellant tank — a composite structure manufacturing defect — pushes initial launch into 2027. Management is using the delay to parallelize Archimedes engine production and first-stage structural work, aiming to accelerate the path to the tenth flight milestone. But the company has already booked a loss provision against Neutron Vehicle 2, acknowledging early flights will lose money. The base price has been raised to $70 million, reflecting premium pricing in a supply-starved medium-lift market. What keeps customers from walking is structural: there is no credible alternative medium-lift vehicle available until approximately 2030. Neutron contracts carry real deposits and cancellation penalties — management pointedly contrasted this with competitors' option-heavy order books. The demand-supply imbalance in launch is so acute that a multi-year delay doesn't trigger defections; it merely shifts revenue recognition windows. The Iridium acquisition looms as the company's most consequential bet. Funded by a completed $2.4 billion ATM equity offering, the deal would transform Rocket Lab from a builder and launcher into an owner-operator of a satellite constellation. Management frames it as generational. Combined with a 50/50 split of future Neutron capacity between external customers and internal Space Services missions, the acquisition signals a company building toward vertical control of the full space value chain — manufacture, launch, operate. Financing is diversified and partially non-dilutive. The Department of Defense's Office of Strategic Capital committed $150 million in non-dilutive loans earmarked for Neutron development and production scale-up. But the $2.4 billion ATM raise is pure dilution, and the Iridium transaction costs already hit Q3 operating expenses with $9.4 million in facility fees alone. The competitive moat is real but conditional. Electron's position as the last dedicated small-launch vehicle standing — as competitors exit rideshare — gives pricing power. HASTE suborbital missions command higher ASPs and boost launch segment margins. Vertical integration shields Rocket Lab from subsystem supply chain disruptions, shifting risk to raw materials only. But all of this hinges on Neutron eventually flying, Iridium closing, and the company's capital structure surviving the transition from high-growth cash burn to reusable-vehicle economics. Management projects adjusted EBITDA breakeven within six months of Neutron's first successful flight.